M
Mary Jane Ferraro
Researcher at Harvard University
Publications - 130
Citations - 9838
Mary Jane Ferraro is an academic researcher from Harvard University. The author has contributed to research in topics: Antibacterial agent & Broth microdilution. The author has an hindex of 46, co-authored 130 publications receiving 9042 citations. Previous affiliations of Mary Jane Ferraro include Clinical and Laboratory Standards Institute & University of Texas Health Science Center at San Antonio.
Papers
More filters
Journal ArticleDOI
Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices
TL;DR: An important task of the clinical microbiology laboratory is the performance of antimicrobial susceptibility testing of significant bacterial isolates to detect possible drug resistance in common pathogens and to assure susceptibility to drugs of choice for particular infections.
Journal ArticleDOI
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Sotirios Tsiodras,Sotirios Tsiodras,Howard S. Gold,Howard S. Gold,George Sakoulas,George Sakoulas,George M. Eliopoulos,George M. Eliopoulos,Christine Wennersten,Lata Venkataraman,Robert C. Moellering,Robert C. Moellering,Mary Jane Ferraro +12 more
TL;DR: An MRSA isolate resistant to linezolid is characterised that was recovered from a patient treated with this agent for dialysis-associated peritonitis.
Journal ArticleDOI
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values.
Journal ArticleDOI
Better tests, better care: improved diagnostics for infectious diseases.
Angela M. Caliendo,David N. Gilbert,David N. Gilbert,Christine C. Ginocchio,Kimberly E. Hanson,Larissa S May,Thomas C. Quinn,Thomas C. Quinn,Fred C. Tenover,David Alland,Anne J. Blaschke,Robert A. Bonomo,Karen C. Carroll,Mary Jane Ferraro,Lisa R. Hirschhorn,W. Patrick Joseph,Tobi Karchmer,Ann T MacIntyre,L. Barth Reller,Audrey F. Jackson +19 more
TL;DR: The current diagnostic landscape, including unmet needs and emerging technologies, and the challenges to the development and clinical integration of improved tests are reviewed, and recommendations that address a host of identified barriers are presented.
Journal ArticleDOI
Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae
Virginia M. Pierce,Patricia J. Simner,David Lonsway,Darcie E. Roe-Carpenter,J. Kristie Johnson,William B. Brasso,April M. Bobenchik,Zabrina Lockett,Angella Charnot-Katsikas,Mary Jane Ferraro,Richard B. Thomson,Stephen G. Jenkins,Brandi Limbago,Sanchita Das +13 more
TL;DR: The modified carbapenem inactivation method (mCIM), in which tryptic soy broth was substituted for water during the inactivation step and the length of this incubation was extended, was easy to perform and interpret for Enterobacteriaceae and excellent reproducibility across laboratories.